Leaflet ALGIFEN 500mg / 5mg / 0.1mg tablets

Product code:
W43286001
Quantity:
20
Indicated for:
pain and inflammation
Route of administration:
oral
Substance:
metamizole sodium + pitofenone hydrochloride + fenpiverinium bromide (nonsteroidal anti-inflammatory drug + analgesic and antipyretic)
ATC
A03DA02 — Alimentary tract and metabolism | Antispasmodics in combination with analgesics | Synthetic anticholinergic agents in combination with analgesics

Precautions:

Glaucoma warning

Glaucoma warning

Use caution if you have glaucoma or increased eye pressure.

Anticholinergic effects

Anticholinergic effects

May cause dry mouth, constipation, urinary retention, or blurred vision.

Major drug interactions

Major drug interactions

This medicine may have important interactions with other medicines.

Nephrotoxicity

Nephrotoxicity

This medicine may affect the kidneys.

Pregnancy warning

Pregnancy warning

Use during pregnancy only on medical advice.

Elderly warning

Elderly warning

Older people may have an increased risk of side effects.

Bleeding risk

Bleeding risk

This medicine may increase the risk of bleeding.

Ulcer / gastrointestinal bleeding

Ulcer / gastrointestinal bleeding

This medicine may increase the risk of ulcer or gastrointestinal bleeding.

This combination of metamizole sodium, pitofenone hydrochloride, and fenpiverinium bromide is used to relieve acute moderate to severe pain, especially spasmodic pain such as renal, biliary, or intestinal colic. It has analgesic, antispasmodic, and anti-inflammatory properties.

Metamizole sodium is an analgesic and antipyretic that reduces pain and fever. Pitofenone hydrochloride has a direct muscle-relaxing effect on smooth muscles, reducing spasms. Fenpiverinium bromide, an anticholinergic, enhances the antispasmodic effect by reducing involuntary muscle contractions.

This combination is effective in treating pain associated with spasms of internal organs, such as the gastrointestinal or urinary tract. It can also be used to relieve severe menstrual pain or other conditions involving muscle spasms.

Side effects may include dry mouth, dizziness, nausea, constipation, or allergic reactions. In rare cases, severe reactions such as low blood pressure, breathing difficulties, or serious skin reactions may occur. Patients should inform their doctor about any side effects or other medications they are taking.

Patients must strictly follow the dosage recommended by their doctor, as excessive use can lead to serious adverse effects. It is also contraindicated in certain conditions, such as severe renal or hepatic insufficiency or allergies to any of the components.

General data about ALGIFEN 500mg / 5mg / 0.1mg

Substance:
metamizole sodium + pitofenone hydrochloride + fenpiverinium bromide
Date of latest medicines list:
01-06-2026
Product code:
W43286001
Concentration:
500mg / 5mg / 0.1mg
Pharmaceutical form:
tablets
Quantity:
20
Product type:
Generic medicine
Price:
9.79 RON
Prescription status:
P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Marketing authorisation

Manufacturer:
ZENTIVA S.A. - ROMANIA
Holder:
ZENTIVA S.A. - ROMANIA
Number:
12374/2019/01
Shelf life:
2 years

Pharmaceutical forms available for metamizole sodium + pitofenone hydrochloride + fenpiverinium bromide

Concentrations available for metamizole sodium + pitofenone hydrochloride + fenpiverinium bromide

  • 500mg/2mg/0.02mg/ml
  • 500mg/5mg/0.1mg

Compensation lists for ALGIFEN 500mg / 5mg / 0.1mg Zentiva

C3 - Sublist C - section C3 (children, pregnant women and postpartum women) with 100% discount from the reference price

Price
9.79 RON
Copayment
9.79 RON
Patient
0.00 RON